As of 2024-12-15, the Intrinsic Value of Chromadex Corp (CDXC) is
1.14 USD. This CDXC valuation is based on the model Discounted Cash Flows (Growth Exit 10Y).
With the current market price of 6.12 USD, the upside of Chromadex Corp is
-81.30%.
The range of the Intrinsic Value is 0.81 - 2.49 USD
CDXC Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
(0.54) - 0.11 |
(0.02) |
-100.3% |
| DCF (Growth 10y) |
0.81 - 2.49 |
1.14 |
-81.3% |
| DCF (EBITDA 5y) |
0.49 - 0.53 |
0.50 |
-91.8% |
| DCF (EBITDA 10y) |
1.13 - 1.40 |
1.23 |
-79.9% |
| Fair Value |
0.45 - 0.45 |
0.45 |
-92.72% |
| P/E |
0.51 - 0.92 |
0.64 |
-89.5% |
| EV/EBITDA |
0.65 - 0.72 |
0.67 |
-89.0% |
| EPV |
(1.29) - (1.95) |
(1.62) |
-126.5% |
| DDM - Stable |
0.23 - 1.17 |
0.70 |
-88.6% |
| DDM - Multi |
0.27 - 1.08 |
0.43 |
-93.0% |
CDXC Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
467.45 |
| Beta |
0.37 |
| Outstanding shares (mil) |
76.38 |
| Enterprise Value (mil) |
435.21 |
| Market risk premium |
4.60% |
| Cost of Equity |
7.74% |
| Cost of Debt |
4.25% |
| WACC |
7.74% |